Dental M&A 2026: Ten Shifts DSO Leaders Must Understand Now
Turn adjusted EBITDA and a few practice details into a directional enterprise-value range with our Healthcare Practice Valuation Calculator. Educational and directional, and no email required.
Dental M&A in 2026 has moved from “growth at any cost” to operational discipline, according to new data from TUSK Practice Sales. Although 69% of DSOs plan to increase acquisitions this year, a high-demand, low-supply market will make deals harder to close — TUSK expects this imbalance to persist for nine months. Several large DSOs, including Dental Care Alliance and Affordable Care, have transitioned into lender control following restructuring, signaling the limits of debt-fueled expansion. Meanwhile, private placement memorandum exits rose 57.1% last year, and 78% of DSOs anticipate recapitalization within 12–36 months. DSOs now require minimum 5-year post-close employment terms and are exiting deals over staffing and clinical continuity risks. The era of rapid network expansion is giving way to regional density, financial discipline, and technology investment.
For PE-backed operators and growth-stage DSOs, this shift demands a new acquisition playbook: tighter due diligence on provider risk, regional density over national scatter, and technology infrastructure investment before the next recapitalization cycle. Groups still chasing volume over operational maturity face the same fate as recent restructuring casualties.
While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.